Quest Diagnostics Inc (DGX) / ResearchSEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer
2026-10-22 2026-10-22 2026-10-06 2026-10-02 2026-09-03 2026-08-31 2026-07-29 2026-07-27 2026-07-27 2026-07-27 2026-07-27 2026-07-23 2026-07-23 2026-05-21 2026-05-08 2026-05-01 2026-04-22 2026-04-21 2026-04-06 2026-03-12 2026-02-26 2026-02-10 2026-01-12 2025-10-21 2025-10-21 2025-07-23 2025-07-22 2025-05-22 2025-04-23 2025-04-22 2025-04-04 2025-03-19 2025-03-19 2025-02-20 2025-01-30 2024-10-23 2024-10-22 2024-08-29 2024-08-19 2024-07-24 SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed
Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.
Transaction rows by code · counts, not monetary totals Purchase: 0 transaction rows 0 P Sale: 5 transaction rows 5 S Grant / award: 3 transaction rows 3 A Exercise / conversion: 2 transaction rows 2 M Tax / exercise payment: 0 transaction rows 0 F Gift: 1 transaction rows 1 G P · Purchase S · Sale A · Grant / award M · Exercise / conversion F · Tax / exercise payment G · Gift
17 matching transaction rows.
Transaction / filed Reporting owner Type Security Shares Reported price 2026-09-01 2026-09-03
Davis J. E.10b5-1 checkbox reported
S · SaleDisposed
Common Stock 10000.0 242.72 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
G · GiftDisposed
Common Stock 1000.0 0.0 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
S · SaleDisposed
Common Stock 430.0 244.51 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
S · SaleDisposed
Common Stock 6237.0 243.63 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
S · SaleDisposed
Common Stock 16010.0 242.88 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
M · Exercise / conversionAcquired
Common Stock 22677.0 112.17 2026-08-28 2026-08-31
PREVOZNIK MICHAEL E10b5-1 checkbox reported
M · Exercise / conversionDisposed
Non-Qualifed Stock Option (right to buy)Derivative security
22677.0 112.17 2026-07-28 2026-07-29
DELANEY MARK E10b5-1 checkbox reported
S · SaleDisposed
Common Stock 1600.0 235.18 2026-07-22 2026-07-27
KUPPUSAMY KARTHIK L · Other (see filing)Acquired
Common Stock 37.0 206.81 2026-07-22 2026-07-27
CARTER ROBERT B L · Other (see filing)Acquired
Common Stock 11.0 206.8 2026-07-22 2026-07-27
Gregg Vicky B A · Grant / awardAcquired
Common Stock 72.0 206.81 2026-07-22 2026-07-27
Plewman Patrick L · Other (see filing)Acquired
Common Stock 46.0 206.81 2026-07-22 2026-07-27
MAIN TIMOTHY L L · Other (see filing)Acquired
Common Stock 21.0 206.81 2026-07-22 2026-07-27
SAMAD SAM A · Grant / awardAcquired
Common Stock 102.0 206.81 2026-07-22 2026-07-27
Lassiter Wright III L · Other (see filing)Acquired
Common Stock 6.0 206.81 2026-07-22 2026-07-27
DELANEY MARK E L · Other (see filing)Acquired
Common Stock 34.0 206.81 2026-07-01 2026-07-02
WENTWORTH TIMOTHY C A · Grant / awardAcquired
Phantom Stock UnitsDerivative security
144.0 0.0
Identity & relationships Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete
These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.
SEC issuer · 0001022079 QUEST DIAGNOSTICS INC
Celera Corporation
Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.
No parent relationship is available in this import; this is not proof of independence.
No verified LEI join available.
GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records
Search names and former names View Wikidata identity and references ↗
Quest Diagnostics · alias · wikidata Celera Corporation · subsidiary · wikidata Celera Genomics · subsidiary · wikidata CORNING CLINICAL LABORATORIES INC · former SEC name · 1996-12-13 to 1997-03-19 Explore headquarters map ↗ Revenue in constant purchasing power USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.
Year ended Reported USD revenue CPI-adjusted USD revenue 2024-12-31 $9.87B $10.60B 2023-12-31 $9.25B $10.23B 2022-12-31 $9.88B $11.38B 2021-12-31 $10.79B $13.41B 2020-12-31 $9.44B $12.29B 2019-12-31 $7.73B $10.18B 2018-12-31 $7.53B $10.10B 2017-12-31 $7.40B $10.17B
Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing
Explore the CPI history ↗